Health Highlights: Nov. 7, 2022

Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more
Is surgery always necessary for chronic chest pain? A new clinical trial finds patients' overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more
Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more
Related Posts
Tomar medicamentos para el TDAH no aumenta el riesgo de abuso de drogas en el futuro de un niño: estudio
JUEVES, 6 de julio de 2023 (HealthDay News) -- Los medicamentos estimulantes,...
COVID-19 Leading Cause of Death for U.S. Children, Young People
MONDAY, Feb. 6, 2023 (HealthDay News) -- COVID-19 was a leading cause of death...
¿Podría la ‘terapia de flotación’ ayudar a aliviar la anorexia?
MARTES, 4 de septiembre de 2023 (HealthDay News) -- La terapia de flotación,...
AI Model May Predict COVID-19 Outcomes for Critically Ill
WEDNESDAY, Jan. 19, 2022 (HealthDay News) – Using proteomics data, a machine...
